Correlation Between Travere Therapeutics and Agios Pharm
Can any of the company-specific risk be diversified away by investing in both Travere Therapeutics and Agios Pharm at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Travere Therapeutics and Agios Pharm into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Travere Therapeutics and Agios Pharm, you can compare the effects of market volatilities on Travere Therapeutics and Agios Pharm and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Travere Therapeutics with a short position of Agios Pharm. Check out your portfolio center. Please also check ongoing floating volatility patterns of Travere Therapeutics and Agios Pharm.
Diversification Opportunities for Travere Therapeutics and Agios Pharm
0.45 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Travere and Agios is 0.45. Overlapping area represents the amount of risk that can be diversified away by holding Travere Therapeutics and Agios Pharm in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Agios Pharm and Travere Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Travere Therapeutics are associated (or correlated) with Agios Pharm. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Agios Pharm has no effect on the direction of Travere Therapeutics i.e., Travere Therapeutics and Agios Pharm go up and down completely randomly.
Pair Corralation between Travere Therapeutics and Agios Pharm
Given the investment horizon of 90 days Travere Therapeutics is expected to generate 3.94 times less return on investment than Agios Pharm. But when comparing it to its historical volatility, Travere Therapeutics is 1.07 times less risky than Agios Pharm. It trades about 0.08 of its potential returns per unit of risk. Agios Pharm is currently generating about 0.31 of returns per unit of risk over similar time horizon. If you would invest 4,630 in Agios Pharm on August 31, 2024 and sell it today you would earn a total of 1,236 from holding Agios Pharm or generate 26.7% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Travere Therapeutics vs. Agios Pharm
Performance |
| Timeline |
| Travere Therapeutics |
| Agios Pharm |
Travere Therapeutics and Agios Pharm Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Travere Therapeutics and Agios Pharm
The main advantage of trading using opposite Travere Therapeutics and Agios Pharm positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Travere Therapeutics position performs unexpectedly, Agios Pharm can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Agios Pharm will offset losses from the drop in Agios Pharm's long position.| Travere Therapeutics vs. Cytokinetics | Travere Therapeutics vs. Ventyx Biosciences | Travere Therapeutics vs. Cogent Biosciences | Travere Therapeutics vs. Nuvalent |
| Agios Pharm vs. Mereo BioPharma Group | Agios Pharm vs. Blueprint Medicines Corp | Agios Pharm vs. Day One Biopharmaceuticals | Agios Pharm vs. Biomarin Pharmaceutical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Complementary Tools
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |